A phase II trial of piroxantrone in endometrial cancer: Southwest Oncology Group study 8918.

Malviya, V K; Liu, P Y; Goldberg, D A; Hantel, A; O'Toole, R V; Roach, R W; Conrad, M E; Alberts, D S

Malviya, V K; Liu, P Y; Goldberg, D A; Hantel, A; O'Toole, R V; Roach, R W; Conrad, M E; Alberts, D S.

Affiliation

Malviya VK; Wayne State University, Detroit, MI 48201, USA.

Anticancer Drugs ; 7(5): 527-30, 1996 Jul.

Article in En | MEDLINE | ID: mdl-8862719

Subject(s)

Anthraquinones/therapeutic use; Antineoplastic Agents/therapeutic use; Endometrial Neoplasms/drug therapy; Pyrazoles/therapeutic use; Adult; Aged; Agranulocytosis/chemically induced; Anthraquinones/adverse effects; Female; Humans; Leukopenia/chemically induced; Middle Aged; Nausea/chemically induced; Pyrazoles/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Anthraquinones / Endometrial Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 1996 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links